Topics

Big Brands Poised To Lose US Marketing Exclusivity In 2019

07:41 EDT 20 Mar 2019 | SCRIP

With the first generic versions of blockbuster brands like Advair, Lyrica, Restasis and Sensipar and the first biosimilars of Herceptin...

      

Related Stories

 

Original Article: Big Brands Poised To Lose US Marketing Exclusivity In 2019

NEXT ARTICLE

More From BioPortfolio on "Big Brands Poised To Lose US Marketing Exclusivity In 2019"

Quick Search

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...